205 related articles for article (PubMed ID: 22884539)
21. High dead-space syringe use among people who inject drugs in Tijuana, Mexico.
Rafful C; Zule W; González-Zúñiga PE; Werb D; Medina-Mora ME; Magis-Rodriguez C; Strathdee SA
Am J Drug Alcohol Abuse; 2015 May; 41(3):220-5. PubMed ID: 25695145
[TBL] [Abstract][Full Text] [Related]
22. Is your syringe services program cost-saving to society? A methodological case study.
Des Jarlais DC; Feelemyer J; McKnight C; Knudtson K; Glick SN
Harm Reduct J; 2021 Dec; 18(1):126. PubMed ID: 34876135
[TBL] [Abstract][Full Text] [Related]
23. The association between neighborhood socioeconomic disadvantage and high-risk injection behavior among people who inject drugs.
DeCuir J; Lovasi GS; El-Sayed A; Lewis CF
Drug Alcohol Depend; 2018 Feb; 183():184-191. PubMed ID: 29288913
[TBL] [Abstract][Full Text] [Related]
24. Factors associated with obtaining sterile syringes from pharmacies among persons who inject drugs in 20 US cities.
Zlotorzynska M; Weidle PJ; Paz-Bailey G; Broz D;
Int J Drug Policy; 2018 Dec; 62():51-58. PubMed ID: 30359873
[TBL] [Abstract][Full Text] [Related]
25. Sharing of Needles and Syringes among Men Who Inject Drugs: HIV Risk in Northwest Bangladesh.
Pasa MK; Alom KR; Bashri Z; Vermund SH
PLoS One; 2016; 11(2):e0148276. PubMed ID: 26848756
[TBL] [Abstract][Full Text] [Related]
26. The effect of on-site and outreach-based needle and syringe programs in people who inject drugs in Kermanshah, Iran.
Nazari SS; Noroozi M; Soori H; Noroozi A; Mehrabi Y; Hajebi A; Sharifi H; Higgs P; Mirzazadeh A
Int J Drug Policy; 2016 Jan; 27():127-31. PubMed ID: 26764125
[TBL] [Abstract][Full Text] [Related]
27. Injection Behaviors and Use of Syringe Service Programs over Time among People Who Inject Drugs in Baltimore, Maryland.
German D; Glick JL; Yenokyan K; Genberg B; Sawyer A; Gribbin M; Flynn C
Subst Use Misuse; 2024; 59(5):651-664. PubMed ID: 38115628
[No Abstract] [Full Text] [Related]
28. Prevalence and risk factors for injection site skin infections among people who inject drugs (PWID) in Tehran.
Noroozi M; Armoon B; Ghisvand H; Noroozi A; Karimy M; Bazrafshan MR; Marshall BDL; Dieji B
J Cosmet Dermatol; 2019 Feb; 18(1):258-262. PubMed ID: 29781249
[TBL] [Abstract][Full Text] [Related]
29. Australia's response to HIV among people who inject drugs.
Madden A; Wodak A
AIDS Educ Prev; 2014 Jun; 26(3):234-44. PubMed ID: 24846486
[TBL] [Abstract][Full Text] [Related]
30. Estimation of the cost-effectiveness of HIV prevention portfolios for people who inject drugs in the United States: A model-based analysis.
Bernard CL; Owens DK; Goldhaber-Fiebert JD; Brandeau ML
PLoS Med; 2017 May; 14(5):e1002312. PubMed ID: 28542184
[TBL] [Abstract][Full Text] [Related]
31. The Effectiveness of Low Dead Space Syringes for Reducing the Risk of Hepatitis C Virus Acquisition Among People Who Inject Drugs: Findings From a National Survey in England, Wales, and Northern Ireland.
Trickey A; Croxford S; Emanuel E; Ijaz S; Hickman M; Kesten J; Thomas C; Edmundson C; Desai M; Vickerman P
Clin Infect Dis; 2022 Sep; 75(6):1073-1077. PubMed ID: 35184173
[TBL] [Abstract][Full Text] [Related]
32. The cost-effectiveness of harm reduction.
Wilson DP; Donald B; Shattock AJ; Wilson D; Fraser-Hurt N
Int J Drug Policy; 2015 Feb; 26 Suppl 1():S5-11. PubMed ID: 25727260
[TBL] [Abstract][Full Text] [Related]
33. Evaluating the impact of global fund withdrawal on needle and syringe provision, cost and use among people who inject drugs in Tijuana, Mexico: a costing analysis.
Cepeda JA; Burgos JL; Kahn JG; Padilla R; Meza Martinez PE; Segovia LA; Gaines T; Abramovitz D; Rangel G; Magis-Rodriguez C; Vickerman P; Strathdee SA; Martin NK
BMJ Open; 2019 Jan; 9(1):e026298. PubMed ID: 30700490
[TBL] [Abstract][Full Text] [Related]
34. Changes in Reported Injection Behaviors Following the Public Health Response to an HIV Outbreak Among People Who Inject Drugs: Indiana, 2016.
Dasgupta S; Broz D; Tanner M; Patel M; Halleck B; Peters PJ; Weidle PJ; O'Donnell J; Amlung J; McAlister C; Chapman E; Bailey A; Burnett J; Duwve J
AIDS Behav; 2019 Dec; 23(12):3257-3266. PubMed ID: 31313095
[TBL] [Abstract][Full Text] [Related]
35. Operationalizing the HIV prevention cascade for PWID using the integrated bio-behavioural survey data from Ukraine.
Dumchev K; Sazonova Y; Smyrnov P; Cheshun O; Pashchuk O; Saliuk T; Varetska O
J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25509. PubMed ID: 32602659
[TBL] [Abstract][Full Text] [Related]
36. Modeling the effect of high dead-space syringes on the human immunodeficiency virus (HIV) epidemic among injecting drug users.
Bobashev GV; Zule WA
Addiction; 2010 Aug; 105(8):1439-47. PubMed ID: 20528817
[TBL] [Abstract][Full Text] [Related]
37. Usage of low dead space syringes and association with hepatitis C prevalence amongst people who inject drugs in the UK.
Trickey A; May MT; Hope V; Ward Z; Desai M; Heinsbroek E; Hickman M; Vickerman P
Drug Alcohol Depend; 2018 Nov; 192():118-124. PubMed ID: 30245460
[TBL] [Abstract][Full Text] [Related]
38. An economic analysis of needle exchange and pharmacy-based programs to increase sterile syringe availability for injection drug users.
Lurie P; Gorsky R; Jones TS; Shomphe L
J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S126-32. PubMed ID: 9663635
[TBL] [Abstract][Full Text] [Related]
39. Pharmacy-randomized intervention delivering HIV prevention services during the syringe sale to people who inject drugs in New York City.
Lewis CF; Rivera AV; Crawford ND; DeCuir J; Amesty S
Drug Alcohol Depend; 2015 Aug; 153():72-7. PubMed ID: 26118831
[TBL] [Abstract][Full Text] [Related]
40. Heroin type, injecting behavior, and HIV transmission. A simulation model of HIV incidence and prevalence.
Bobashev G; Mars S; Murphy N; Dreisbach C; Zule W; Ciccarone D
PLoS One; 2019; 14(12):e0215042. PubMed ID: 31887142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
